Factory-CRO Group, a medical device and in vitro diagnostics-focused CRO based in the Netherlands, has merged with U.S.-based Boston Biomedical Associates.
Financial terms of the deal weren’t announced.
With the addition of Boston Biomedical, Factory-CRO Group now boasts expanded operations in the U.S., as well as sites in Australia, New Zealand and Europe. Factory-CRO Group said its goal is to become the leading global CRO focused on medical devices and medical technology.
“This merger allows us to provide our specialized expertise and a continued commitment to the highest level of customized service to a larger audience,” Dirk Meijer, M.D., Ph.D., the company’s chief executive, said in a statement. “We operate from our own offices located within each region housed with employees that have refined expertise to meet our unique client needs.”
A little over a year ago, Factory-CRO Group acquired Milestone Research Organization. Factory-CRO Group offers medical device companies services in data management, consultancy regarding study design and budget and regulatory strategy, regulatory filings, clinical monitoring and reimbursement.